MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
12.27
-0.01 (-0.08%)
Jan 22, 2026, 4:00 PM EST - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $57.6 million as of January 22, 2026. Its market cap has increased by 63.85% in one year.
Market Cap
57.60M
Enterprise Value
49.09M
1-Year Change
63.85%
Ranking
Category
Stock Price
$12.27
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $57.60M, a decrease of -85.09%. That is a compound annual growth rate of -35.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 57.64M | 10.13% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |